{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:37:42Z","timestamp":1789731462261,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00066-018-1306-2","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T05:32:02Z","timestamp":1524634322000},"page":"835-842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery","LINAC-basierte K\u00f6rperstereotaxie beim nichtresektablen lokal fortgeschrittenen Pankreaskarzinom: Risikoadaptierte Dosisverordnung und bildgesteuerte Dosisverteilung"],"prefix":"10.1007","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2838-7337","authenticated-orcid":false,"given":"Rosario","family":"Mazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fersino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Gregucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Tebano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioacchino","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tondulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Ruffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"issue":"4","key":"1306_CR1","doi-asserted-by":"publisher","first-page":"e1000267","DOI":"10.1371\/journal.pmed.1000267","volume":"7","author":"S Gillen","year":"2010","unstructured":"Gillen S, Schuster T, Meyer Zum B\u00fcschenfelde C et al (2010) Preoperative\/neoadjuvant therapy in pancreatic cancer: a\u00a0systematic review and meta-analysis of response and resection percentages. Plos Med 7(4):e1000267","journal-title":"Plos Med"},{"issue":"5","key":"1306_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1245\/s10434-011-2110-8","volume":"19","author":"A Andriulli","year":"2012","unstructured":"Andriulli A, Festa V, Botteri E et al (2012) Neoadjuvant\/Preoperative gemcitabine for patients with localized pancreatic cancer: a\u00a0meta-analysis of prospective studies. Ann Surg Oncol 19(5):1644\u20131662","journal-title":"Ann Surg Oncol"},{"key":"1306_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2016.05.003","volume":"103","author":"B Bari De","year":"2016","unstructured":"De Bari B, Porta L, Mazzola R et\u00a0al (2016) Hypofractionated radiotherapy in pancreatic cancer: lessons from the past in the era of stereotactic body radiation therapy. Crit Rev Oncol Hematol 103:49\u201361","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"1306_CR4","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1016\/j.ijrobp.2011.04.045","volume":"81","author":"A Mahadevan","year":"2011","unstructured":"Mahadevan A, Miksad R, Goldstein M et\u00a0al (2011) Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 81(4):e615\u201322","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1306_CR5","first-page":"2149","volume":"35","author":"F Alongi","year":"2015","unstructured":"Alongi F, Mazzola R, Ricchetti F et al (2015) Volumetric-modulated arc therapy with vaginal cuff simultaneous integrated boost as an alternative to brachytherapy in adjuvant irradiation for endometrial cancer: a\u00a0prospective study. Anticancer Res 35(4):2149\u20132155","journal-title":"Anticancer Res"},{"issue":"12","key":"1306_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11547-015-0555-8","volume":"120","author":"G Ferrera","year":"2015","unstructured":"Ferrera G, Mortellaro G, Mannino M et\u00a0al (2015) Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales. Radiol Med 120(12):1170\u20131176","journal-title":"Radiol Med"},{"issue":"8","key":"1306_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s11547-015-0512-6","volume":"120","author":"R Mazzola","year":"2015","unstructured":"Mazzola R, Ferrera G, Alongi F et al (2015) Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a\u00a0mono-institutional experience. Radiol Med 120(8):753\u2013758","journal-title":"Radiol Med"},{"key":"1306_CR8","volume-title":"Pancreatic adenocarcinoma. Version 2","author":"NCCN Clinical Practice Guidelines in Oncology","year":"2017","unstructured":"NCCN Clinical Practice Guidelines in Oncology (2017) Pancreatic adenocarcinoma. Version 2. \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/pancreatic.pdf\n                    \n                  . Accessed 1 May 2017"},{"issue":"3","key":"1306_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/1533034616650778","volume":"16","author":"T Comito","year":"2017","unstructured":"Comito T, Cozzi L, Clerici E et\u00a0al (2017) Can Stereotactic body radiation therapy be a\u00a0viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a\u00a0phase 2 study. Technol Cancer Res Treat 16(3):295\u2013301","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"1306_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejso.2016.12.012","volume":"43","author":"T Comito","year":"2017","unstructured":"Comito T, Cozzi L, Zerbi A et\u00a0al (2017) Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: a retrospective study. Eur J Surg Oncol 43(4):735\u2013742","journal-title":"Eur J Surg Oncol"},{"key":"1306_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E et al (2016) RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer 62:132\u2013137","journal-title":"Eur J Cancer"},{"issue":"suppl 1","key":"1306_CR12","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y et\u00a0al (2009) From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J\u00a0Nucl Med 50(suppl 1):122S\u2013150S","journal-title":"J Nucl Med"},{"issue":"7","key":"1306_CR13","first-page":"619","volume":"30","author":"W Small Jr","year":"2016","unstructured":"Expert Panel on Radiation Oncology-Gastrointestinal, Small W Jr, Hayes JP, Suh WW et al (2016) ACR appropriateness criteria\u00ae borderline and unresectable pancreas cancer. Oncology 30(7):619\u201324, 627, 632","journal-title":"Oncology"},{"issue":"3","key":"1306_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ijrobp.2008.01.051","volume":"72","author":"D Schellenberg","year":"2008","unstructured":"Schellenberg D, Goodman KA, Lee F et al (2008) Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 72(3):678\u2013686","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1306_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ijrobp.2003.11.004","volume":"58","author":"AC Koong","year":"2004","unstructured":"Koong AC, Le QT, Ho A et\u00a0al (2004) Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58(4):1017\u20131021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1306_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijrobp.2005.07.002","volume":"63","author":"AC Koong","year":"2005","unstructured":"Koong AC, Christofferson E, Le QT et\u00a0al (2005) Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a\u00a0stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 63(2):320\u2013323","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1306_CR17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.5732\/cjc.010.10112","volume":"29","author":"ZT Shen","year":"2010","unstructured":"Shen ZT, Wu XH, Li B et\u00a0al (2010) Preliminary efficacy of CyberKnife radiosurgery for locally advanced pancreatic cancer. Chin J Cancer 29(9):802\u2013809","journal-title":"Chin J Cancer"},{"issue":"7","key":"1306_CR18","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/cncr.29161","volume":"121","author":"JM Herman","year":"2015","unstructured":"Herman JM, Chang DT, Goodman KA et al (2015) Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer 121(7):1128\u20131137","journal-title":"Cancer"},{"key":"1306_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2016.09.002","author":"DAS Toesca","year":"2017","unstructured":"Toesca DAS, Pollom EL et\u00a0al (2017) Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET. Pract Radiat Oncol. \n                    https:\/\/doi.org\/10.1016\/j.prro.2016.09.002","journal-title":"Pract. Radiat. Oncol."},{"issue":"12","key":"1306_CR20","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00066-016-1057-x","volume":"192","author":"TB Brunner","year":"2016","unstructured":"Brunner TB, Nestle U, Adebahr S et al (2016) Simultaneous integrated protection: a new concept for high-precision radiation therapy. Strahlenther Onkol 192(12):886\u2013894","journal-title":"Strahlenther Onkol"},{"issue":"12","key":"1306_CR21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00066-016-1053-1","volume":"192","author":"C Panje","year":"2016","unstructured":"Panje C, Andratschke N, Brunner TB et\u00a0al (2016) Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer: literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 192(12):875\u2013885","journal-title":"Strahlenther Onkol"},{"key":"1306_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/cncr.24059","volume":"115","author":"DT Chang","year":"2009","unstructured":"Chang DT, Schellenberg D, Shen J et\u00a0al (2009) Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115:665\u2013672","journal-title":"Cancer"},{"issue":"2","key":"1306_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jss.2011.07.044","volume":"174","author":"K Goyal","year":"2012","unstructured":"Goyal K, Einstein D, Ibarra RA et\u00a0al (2012) Stereotactic body radiation therapy for nonresectable tumors of the pancreas. J\u00a0Surg Res 174(2):319\u2013325","journal-title":"J Surg Res"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1306-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1306-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1306-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T19:20:11Z","timestamp":1556133611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1306-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,25]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1306-2","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,25]]},"assertion":[{"value":"17 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"R.\u00a0Mazzola, S.\u00a0Fersino, D.\u00a0Aiello, F.\u00a0Gregucci, U.\u00a0Tebano, S.\u00a0Corradini, G.\u00a0Di Paola, M.\u00a0Cirillo, L.\u00a0Tondulli, G.\u00a0Ruffo, R.\u00a0Ruggieri, and F.\u00a0Alongi declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}